Use of in-house strains in mandatory microbiological assays in the pharmaceutical industry and the importance of deposition in biological collections

Key Points

• The research aims to highlight the significance of in-house strains for mandatory microbiological assays in the pharmaceutical sector.
• In-house strain utilization for microbiological assays in pharmaceutical settings.
• Evaluation conducted during the International Symposium on Immunobiologicals.
• Collaboration with Instituto de Tecnologia em Imunobiológicos.
• Discussion around the standardization of microbiological assays using in-house strains.
• Implications for the improvement of pharmaceutical quality control.
• Insights into the role of biological collections in the industry.

Abstract